BR9712546A - Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende - Google Patents

Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende

Info

Publication number
BR9712546A
BR9712546A BR9712546-6A BR9712546A BR9712546A BR 9712546 A BR9712546 A BR 9712546A BR 9712546 A BR9712546 A BR 9712546A BR 9712546 A BR9712546 A BR 9712546A
Authority
BR
Brazil
Prior art keywords
adjuvant
notably
emulsion containing
metal cation
vaccine composition
Prior art date
Application number
BR9712546-6A
Other languages
English (en)
Inventor
Vincent Ganne
Jerome Aucouturier
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Publication of BR9712546A publication Critical patent/BR9712546A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção:<B>"ADJUVANTE, NOTADAMENTE SOB A FORMA DE UMA EMULSãO CONTENDO UM CáTION METáLICO TRIVALENTE E COMPOSIçãO VACINAL QUE A COMPREENDE"<D>. Composição compreendendo: (I) pelo menos um antígeno ou pelo menos um gerador in vivo de um composto que compreende uma seq³ência de ácidos aminados; e (II) pelo menos um adjuvante, caracterizado pelo fato de esse adjuvante conter pelo menos um compostos simpatomimético e sua utilização como medicamento.
BR9712546-6A 1996-10-18 1997-10-10 Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende BR9712546A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612718A FR2754715B1 (fr) 1996-10-18 1996-10-18 Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
PCT/FR1997/001816 WO1998017311A1 (fr) 1996-10-18 1997-10-10 Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant

Publications (1)

Publication Number Publication Date
BR9712546A true BR9712546A (pt) 1999-10-19

Family

ID=9496796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712546-6A BR9712546A (pt) 1996-10-18 1997-10-10 Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende

Country Status (6)

Country Link
EP (1) EP0939649B1 (pt)
JP (1) JP3329471B2 (pt)
BR (1) BR9712546A (pt)
DE (1) DE69711673T2 (pt)
FR (1) FR2754715B1 (pt)
WO (1) WO1998017311A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408615B (de) * 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
FR2800280B1 (fr) * 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
FR2955776A1 (fr) 2010-02-01 2011-08-05 Seppic Sa Utilisation d'une huile minerale specifique pour la fabrication d'un nouveau adjuvant
FR2955775B1 (fr) 2010-02-01 2012-05-04 Seppic Sa Adjuvant pour la preparation de compositions vaccinales destinees a la prevention contre les coccidioses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines

Also Published As

Publication number Publication date
JP3329471B2 (ja) 2002-09-30
JP2000507610A (ja) 2000-06-20
EP0939649A1 (fr) 1999-09-08
FR2754715A1 (fr) 1998-04-24
DE69711673D1 (de) 2002-05-08
FR2754715B1 (fr) 1998-11-13
WO1998017311A1 (fr) 1998-04-30
EP0939649B1 (fr) 2002-04-03
DE69711673T2 (de) 2002-11-21

Similar Documents

Publication Publication Date Title
BR9812133A (pt) Análogos de gaba para prevenir e tratar danos gastrintestinais
BR9814276A (pt) Antìgenos de superfìcie
DE69532760D1 (de) Mittel zur verabreichung von antigenen
NO20033918L (no) Ny anvendelse av peptidklasse av forbindelser for behandling av allodyni eller andre typer av kronisk smerte eller fantomsmerte
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
BR0115696A (pt) Uso de bisfosfonatos para tratamento de dor
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
MXPA02012434A (es) Anticuerpos que se unen inmunoespecificamente a estimulador de linfocitos ii.
WO2003055979A3 (en) ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
ES2069843T3 (es) Utilizacion de baclofen para la obtencion de medicamentos destinados al tratamiento de la angina de pecho.
PT94138A (pt) Processo de preparacao de uma forma farmaceutica porosa a base de ciclodextrina
BR0103736A (pt) Uso de uma composição que compreende pelo menos um composto metalo-orgânico e processo de tratamento das matérias queratìnicas
BR9608067A (pt) Composição terapêutica compreendendo um antígeno ou um gerador in vivo de um composto que compreende uma sequência de ácidos aminados
ATE72963T1 (de) Konditionierfluessigkeiten von zahn- oder knochensubstanz.
SE8303696D0 (sv) Farmakologiska kompositioner
BR9712546A (pt) Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende
BR0011469A (pt) Gm-csf equina
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
BR9811643A (pt) Suplementação quìmica de osso
DE69626522D1 (de) Peptide mit pronociceptiveigenschaften
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
LV11821A (lv) Savienojumu ar fosfonamida vai enola fosfata saiti pielietojums audzeju arstesanai
EA200501231A1 (ru) Применение дипиридамола в комбинации с ацетилсалициловой кислотой и антагонистом ангиотензина ii для предупреждения инсульта
BR9808729A (pt) Processo para a preparação de um anti-oxidante
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1872 DE 21/11/2006.